ESSA Pharma Inc (EPIX)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: EPIX Exchange: NAS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2024-05-06 2024-05-06 PS Planned sale

Virsik Peter

Chief Operating Officer

Officer
1,000 -5.8%
6.95
100,000 USD 		1,000 -5.8% 6.95 100,000 USD
2024-04-05 2024-04-05 PS Planned sale

Virsik Peter

Chief Operating Officer

Officer
694 -5.5%
7.94
5,510 USD 		694 -5.5% 7.94 5,510 USD
2024-04-05 2024-04-05 PS Planned sale

Virsik, Peter

Director of Issuer

Non-Executive Director
694 -5.5%
7.94
5,510 USD 		694 -5.5% 7.94 5,510 USD
2024-03-05 2024-03-05 PS Planned sale

Virsik Peter

Chief Operating Officer

Officer
694 -5.2%
8.98
6,232 USD 		694 -5.2% 8.98 6,232 USD
2024-02-07 2024-02-06 PS Planned sale

Virsik Peter

Chief Operating Officer

Officer
72,782 -84.5%
10.29
748,927 USD 		72,782 -84.5% 10.29 748,927 USD
2024-02-06 2024-02-05 PS Planned sale

Virsik Peter

Chief Operating Officer

Officer
500 -3.6%
10.04
5,020 USD 		500 -3.6% 10.04 5,020 USD
2024-02-06 2024-02-05 PS Planned sale

Virsik Peter

Chief Operating Officer

Officer
694 -4.9%
9.25
6,420 USD 		694 -4.9% 9.25 6,420 USD
2024-01-17 2024-01-16 PS Planned sale

Virsik Peter

Chief Operating Officer

Officer
1,718 -10.9%
10.01
17,197 USD 		1,718 -10.9% 10.01 17,197 USD
2024-01-11 2024-01-05 PS Planned sale

Virsik, Peter

Director of Issuer

Non-Executive Director
699 -4.7%
6.11
4,271 USD 		699 -4.7% 6.11 4,271 USD
2024-01-08 2024-01-05 PS Planned sale

Virsik Peter

Chief Operating Officer

Officer
699 -4.7%
6.11
4,271 USD 		699 -4.7% 6.11 4,271 USD
2023-12-18 2023-12-14 B Purchase

Parkinson, David

Director of Issuer

Non-Executive Director
9,223 +16.3%
2.30
21,250 USD 		9,223 +16.3% 2.30 21,250 USD
2023-12-18 2023-12-14 PP Planned purchase

Parkinson David Ross

Chief Executive Officer

Executive Director
9,223 +16.3%
2.30
21,213 USD 		9,223 +16.3% 2.30 21,213 USD
2023-11-22 2023-11-21 B Purchase

BERGER FRANKLIN M

Non-Executive Director
23,259 +3.1%
5.73
133,274 USD 		23,259 +3.1% 5.73 133,274 USD
2023-11-16 2023-11-03 B Purchase

BERGER FRANKLIN M

Non-Executive Director
16,471 +2.2%
5.99
98,661 USD 		16,471 +2.2% 5.99 98,661 USD
2023-11-16 2023-11-02 B Purchase

BERGER FRANKLIN M

Non-Executive Director
60,000 +8.8%
5.35
321,000 USD 		60,000 +8.8% 5.35 321,000 USD
2023-01-05 2022-12-30 PP Planned purchase

Wood, David Sidney

Senior Officer of Issuer

Officer
8,302 +33.2%
2.60
21,585 USD 		8,302 +33.2% 2.60 21,585 USD
2023-01-05 2022-12-30 PP Planned purchase

Parkinson, David

Director of Issuer

Non-Executive Director
3,067 +5.7%
2.60
7,974 USD 		3,067 +5.7% 2.60 7,974 USD
2023-01-05 2022-12-30 PP Planned purchase

Parkinson David Ross

Chief Executive Officer

Executive Director
3,067 +5.7%
2.60
7,974 USD 		3,067 +5.7% 2.60 7,974 USD
2023-01-05 2022-12-30 PP Planned purchase

Wood David S.

Chief Financial Officer

Officer
8,302 +33.2%
2.60
21,585 USD 		8,302 +33.2% 2.60 21,585 USD
2023-01-05 2022-12-22 B Purchase

Parkinson, David

Director of Issuer

Non-Executive Director
21,367 +66.5%
2.39
51,067 USD 		21,367 +66.5% 2.39 51,067 USD
2023-01-05 2022-12-22 B Purchase

Parkinson David Ross

Chief Executive Officer

Executive Director
21,367 +66.5%
2.39
51,067 USD 		21,367 +66.5% 2.39 51,067 USD
2023-01-05 2022-12-21 S Sale

BERGER, FRANKLIN MILAN

Director of Issuer

Non-Executive Director
34,334 -4.8%
2.42
83,088 USD 		34,334 -4.8% 2.42 83,088 USD
2023-01-05 2022-12-21 S Sale

BERGER, FRANKLIN MILAN

Director of Issuer

Non-Executive Director
37,889 -5.0%
2.41
91,312 USD 		37,889 -5.0% 2.41 91,312 USD
2023-01-05 2022-12-21 S Sale

BERGER FRANKLIN M

Non-Executive Director
34,334 -4.8%
2.42
83,088 USD 		34,334 -4.8% 2.42 83,088 USD
2023-01-05 2022-12-21 S Sale

BERGER FRANKLIN M

Non-Executive Director
37,889 -5.0%
2.41
91,312 USD 		37,889 -5.0% 2.41 91,312 USD
2023-01-05 2022-12-20 S Sale

BERGER, FRANKLIN MILAN

Director of Issuer

Non-Executive Director
43,617 -5.5%
2.53
110,351 USD 		43,617 -5.5% 2.53 110,351 USD
2023-01-05 2022-12-20 S Sale

BERGER FRANKLIN M

Non-Executive Director
43,617 -5.5%
2.53
110,351 USD 		43,617 -5.5% 2.53 110,351 USD
2023-01-05 2022-12-16 S Sale

BERGER, FRANKLIN MILAN

Director of Issuer

Non-Executive Director
50,000 -5.9%
2.67
133,500 USD 		50,000 -5.9% 2.67 133,500 USD
2023-01-05 2022-12-16 S Sale

BERGER FRANKLIN M

Non-Executive Director
50,000 -5.9%
2.67
133,500 USD 		50,000 -5.9% 2.67 133,500 USD
2023-01-05 2022-12-15 S Sale

BERGER, FRANKLIN MILAN

Director of Issuer

Non-Executive Director
50,000 -5.6%
2.86
143,000 USD 		50,000 -5.6% 2.86 143,000 USD
2023-01-05 2022-12-15 S Sale

BERGER, FRANKLIN MILAN

Director of Issuer

Non-Executive Director
32,000 -3.4%
2.90
92,800 USD 		32,000 -3.4% 2.90 92,800 USD
2023-01-05 2022-12-15 S Sale

BERGER FRANKLIN M

Non-Executive Director
50,000 -5.6%
2.86
143,000 USD 		50,000 -5.6% 2.86 143,000 USD
2023-01-05 2022-12-15 S Sale

BERGER FRANKLIN M

Non-Executive Director
32,000 -3.4%
2.90
92,800 USD 		32,000 -3.4% 2.90 92,800 USD
2023-01-05 2022-12-14 S Sale

BERGER, FRANKLIN MILAN

Director of Issuer

Non-Executive Director
25,000 -2.6%
3.00
75,000 USD 		25,000 -2.6% 3.00 75,000 USD
2023-01-05 2022-12-14 S Sale

BERGER FRANKLIN M

Non-Executive Director
25,000 -2.6%
3.00
75,000 USD 		25,000 -2.6% 3.00 75,000 USD
2022-10-28 2022-10-27 B Purchase

BIOTECH GROWTH N V

Large shareholder
500,000 +6.8%
4.50
2,251,100 USD 		500,000 +6.8% 4.50 2,251,100 USD
2022-10-28 2022-10-26 B Purchase

BIOTECH GROWTH N V

Large shareholder
1,500,000 +25.5%
3.98
5,968,500 USD 		1,500,000 +25.5% 3.98 5,968,500 USD
2022-07-20 2022-07-18 B Purchase

BIOTECH GROWTH N V

Large shareholder
300,000 +5.4%
3.16
946,740 USD 		300,000 +5.4% 3.16 946,740 USD
2022-07-18 2022-07-15 B Purchase

BIOTECH GROWTH N V

Large shareholder
241,665 +4.5%
3.13
756,798 USD 		241,665 +4.5% 3.13 756,798 USD
2022-07-18 2022-07-14 B Purchase

BIOTECH GROWTH N V

Large shareholder
347,204 +7.0%
2.79
969,428 USD 		347,204 +7.0% 2.79 969,428 USD
2022-07-05 2022-06-30 B Purchase

Parkinson David Ross

Chief Executive Officer

Executive Director
4,887 +18.0%
2.96
14,456 USD 		4,887 +18.0% 2.96 14,456 USD
2022-04-28 2022-04-27 S Sale

BIOTECH GROWTH N V

Large shareholder
25,100 -0.5%
5.85
146,925 USD 		25,100 -0.5% 5.85 146,925 USD
2021-03-04 2021-02-22 B Purchase

BERGER FRANKLIN M

Non-Executive Director
57,000 +6.3%
27.00
1,539,000 USD 		57,000 +6.3% 27.00 1,539,000 USD